Rare Respiratory Diseases: A Personal and a Public Health Problem

Dear Colleagues, A rare disease, also known as an orphan disease, is any disease that affects a small percentage of the population. Although definitions vary from continent to continent, according to the European Union, rare diseases are those with a prevalence of less than 1 in 2000 people. Rare di...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (242 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04200nam-a2201009z--4500
001 993545313804498
005 20231214133254.0
006 m o d
007 cr|mn|---annan
008 202205s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5680000000037586 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/81230 
035 |a (EXLCZ)995680000000037586 
041 0 |a eng 
100 1 |a Dasí, Francisco  |4 edt 
245 1 0 |a Rare Respiratory Diseases: A Personal and a Public Health Problem 
246 |a Rare Respiratory Diseases 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (242 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Dear Colleagues, A rare disease, also known as an orphan disease, is any disease that affects a small percentage of the population. Although definitions vary from continent to continent, according to the European Union, rare diseases are those with a prevalence of less than 1 in 2000 people. Rare diseases are, in general, chronic, debilitating diseases, which in many cases threaten patients’ lives. It is estimated that 1–2 million people in the European Union are affected by a rare respiratory disease, which is a public health problem. Due to the low prevalence and severity of many of these diseases, whose symptoms often initially manifest in childhood, combined efforts are needed to improve our knowledge of the pathophysiology of these diseases that will lead to the development of new, more effective treatments. Therefore, since rare respiratory diseases represent an important field in medicine, we propose this Special Issue to promote the dissemination of the latest advances in basic and clinical research in these diseases. Prof. Dr. Francisco Dasí Guest Editor 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Pharmacology  |2 bicssc 
653 |a standard diagnosis 
653 |a reference centres 
653 |a clinical presentation 
653 |a cilia 
653 |a primary ciliary dyskinesia 
653 |a alpha-1 antitrypsin deficiency 
653 |a rare respiratory diseases 
653 |a Mycobacterium avium 
653 |a Mycobacterium intracellulare 
653 |a nodular bronchiectasis 
653 |a non-tuberculous mycobacteria 
653 |a pulmonary aspergillosis 
653 |a rare pulmonary disease 
653 |a miRNA expression 
653 |a exhaled breath condensate 
653 |a sputum 
653 |a severity 
653 |a pulmonary exacerbation 
653 |a alpha1 antitrypsin deficiency 
653 |a augmentation therapy 
653 |a replacement therapy 
653 |a rare diseases 
653 |a gene therapy 
653 |a alpha-1-antitrypsin deficit 
653 |a cystic fibrosis 
653 |a neonatal respiratory distress 
653 |a laterality defect 
653 |a orphan diseases 
653 |a PCD 
653 |a immunofluorescence 
653 |a antibody 
653 |a ALI culture 
653 |a bio-resource 
653 |a primary nasal epithelium 
653 |a diagnostics 
653 |a Alpha-1 antitrypsin deficiency 
653 |a liver disease 
653 |a glutamate-oxaloacetate transaminase 
653 |a glutamate-pyruvate transaminase 
653 |a gamma-glutamyl transpeptidase 
653 |a resilience 
653 |a active lifestyle 
653 |a stress levels 
653 |a infection control measure 
653 |a self-quarantine 
653 |a flow cytometry 
653 |a nasal epithelium 
653 |a oxidative stress 
653 |a reactive oxygen species 
653 |a endoplasmic reticulum stress 
653 |a antioxidant therapies 
653 |a idiopathic pulmonary fibrosis 
653 |a chronic obstructive pulmonary disease 
653 |a bronchiectasis 
653 |a asthma 
653 |a emphysema 
653 |a alpha1-antitrypsin deficiency 
653 |a transient elastography 
776 |z 3-0365-3669-8 
776 |z 3-0365-3670-1 
700 1 |a Dasí, Francisco  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:48:48 Europe/Vienna  |f system  |c marc21  |a 2022-05-14 21:41:54 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337856670004498&Force_direct=true  |Z 5337856670004498  |b Available  |8 5337856670004498